AKT1 and cancer: Activating mutations in key factors of the PI3K/AKT/mTOR pathway, such as TIE2, PIK3CA, AKT, or MAP3K3, lead to the activation of PI3K signaling and uncontrolled cell proliferation in many human cancers [76].